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ABSTRACT The extracellular availability of growth factors, hormones, chemokines, and neurotransmitters under gradient
conditions is required for directional cellular responses such as migration, axonal pathﬁnding, and tissue patterning. These
responsesare, in turn, important in diseaseanddevelopmental processes. This article addresses critical barriers towarddevising a
chemotaxis assay that is broadly applicable for different kinds of cancer cells through the design of a microﬂuidic chamber that
produces a steep gradient of chemoattractant. Photolithography was used to create microchannels for chemoattractant delivery,
ﬂow diversion barriers/conduits, and small outlets in the form of apertures. The 1-mmapertures weremade at the active surface by
uncapping a thin (1.5 mm) layer of AZ1518. This process also created a vertical conduit that diverted the ﬂow such that it occurred
perpendicularly to the active, experimental surface where the gradients were measured. The other side of the vertical conduit
opened to underlying 20-mm deep channels that carried microﬂuidic ﬂows of tracer dyes/growth factors. Modeled data using
computational ﬂuid dynamics produced gradients that were steep along the horizontal, active surface. This simulation mirrors
empirically derivedgradients obtained from the ﬂowanalysesof ﬂuorescent compounds. Theopenchamber contains a large buffer
volume,which prevents chemoattractant saturation andpermits easy cell and compoundmanipulation. The techniqueobviates the
use of membranes or laminar ﬂow that may hinder imaging, rinsing steps, cell seeding, and treatment. The utility of the chamber in
the study of cell protrusion, an early step during chemotaxis, was demonstrated by growing cancer cells in the chamber, inducing a
chemoattractant gradient using compressed air at 0.7 bar, and performing time-lapse microscopy. Breast cancer cells responded
to the rapidly developed and stable gradient of epidermal growth factor by directing centroid positions toward the gradient and by
forming a leading edge at a speed of 0.45 mm/min.
INTRODUCTION
Chemoattractants such as chemokines and growth factors are
important inducers of cell migration. The factors bind and
activate cell surface receptors that, in turn, trigger down-
stream signal pathways that lead to the reorganization of the
cytoskeleton and other machineries resulting in cell move-
ment. The directional movement of cells in the presence of a
chemoattractant gradient is called ‘‘chemotaxis’’. The early
response of the cell after receptor activation is the generation
of an internal gradient of second messengers that exceed the
strength of the external gradient (1–3). This effect is known
as ‘‘sensing’’ and leads to the polarization of the cell in
forming a distinct leading front and trailing edge. The cell
adheres to the underlying substrate through integrins fol-
lowed by actomyosin contraction that releases the cell, pro-
pelling it forward (4).
Cell migration occurs in a variety of biological processes
such as wound healing, development, and immune responses.
In disease processes such as cancer, migration is involved in
the spread of the disease or metastasis. Cancer cells have been
shown in vivo to actively form protrusions and were migra-
tory in close proximity to blood vessels and host macrophages
(5). Subsequent experiments demonstrated a paracrine rela-
tionship between the cancer cells that expressed the colony-
stimulating factor-1 (CSF-1) ligand and epidermal growth
factor receptor (EGFR) and the macrophages that expressed
the epidermal growth factor (EGF) ligand and the CSF-1 re-
ceptor. The cross-stimulation of the different receptors pro-
moted the migration of these two types of cell (6). Therefore,
the nature of the interactions between the cells is within short
distances, and the gradients of chemoattractant, such as for
EGF, are likely to be steep.
Under in vitro conditions, cancer cells are slow moving
compared to other naturally motile cells such as leukocytes.
Cancer cells also respond poorly to micropipette assays that
create gradients by pressure-driven extrusion of the chemo-
attractants and to other visual-based chemotaxis assays that
are more appropriate for faster moving cells such as neutro-
phils or more polarized cells (7–9). However, modiﬁcation of
the micropipette assay by restricting the chemoattractant ﬂow
to create stable and steep gradients enabled cancer cell che-
motaxis (10). In this study, we reﬁned the assay by devising a
planar, microﬂuidic chamber that recreates similar gradients.
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The transparent device also permits direct viewing with
sufﬁcient throughput for experimental analyses.
The processes of creating small, high aspect ratio features
in thicker substrates normally require anisotropic plasma
etching, which is expensive and which may incur etch bias
anomalies. The method described here, which uses a thin
(1.5-mm), substrate, works well in the lithographic genera-
tion micrometer-size apertures that superimpose over larger
microﬂuidic channels.
The generation of a steep gradient of chemoattractant was
veriﬁed by modeling and experimental data. Culturing of
breast cancer cells, time-lapsed microscopy, and analysis of
parameters such as directionality and instantaneous speed
of cell protrusion were performed. The data indicated that the
cancer cells responded signiﬁcantly more directionally and
rapidly compared to uninduced cells in the presence of an
EGF gradient, demonstrating the value of the planar chamber
for the evaluation of cancer cell behavior.
MATERIALS AND METHODS
Microﬂuidic chamber
The planar device (PD) constitutes three sections that were assembled on top
of each other and kept under positive pressure in a metal chamber. The
bottom layer consists of a glass substrate with patterned polymer microﬂuidic
channels that lead from a reservoir or inlet. A plan-parallel, poly
(dimethylsiloxane) (PDMS) (11) seal of 2-mm thickness overlie this layer. It
serves to seal the reservoir, deﬁne the open tank for extrusion of the che-
moattractant and gradient formation, and distribute the pressure on the as-
sembly evenly. A PMMA block sits on top of the PDMS; the block connects
to a pressure regulator (0–0.7 bar) at an opening that leads to the reservoir.
The whole stack is pressed together in a ﬁtted metal chamber (Fig. 1 A).
The active device as such consists of a thin ﬁlm of an ultraviolet curable
epoxy resin (UV15; Master Bond, Hackensack, NJ) with 20-mm channels
imprinted by means of photolithography (Fig. 2). To seal the channels, a 1.5-
mm thick ﬁlm of AZ1518 (Clariant, Muttenz, Switzerland)) was transferred
onto the UV15 layer and opened lithographically to create 1-mm apertures
that connect the channels to the active surface. The transfer of AZ1518
membranes was performed as described previously (12) with some modiﬁ-
cations. In brief, AZ1518 was spin-coated onto a plan-parallel, wafer-like
PDMS layer of a few millimeters in thickness. After drying in air for 6 min,
the layer was readily transferred onto the UV15 substrate with a softbaking
step at 60C for 3 min. After cooling to room temperature, the PDMS was
peeled off, leaving the photoresist on the device.
Gradient modeling
The EGF concentration gradients in the various devices described in this
article are modeled using computational ﬂuid dynamics to solve the Navier-
Stokes and diffusion equations (13). Two structures are modeled; the mod-
iﬁed micropipette assay (MA) used to create a steep EGF gradient (10) and
the PD presented above. The natures of these geometries lend themselves to
different numerical approaches.
The numerical domain of PD (Fig. 3 A) consists of a 1-mm aperture that
dispenses the EGF solution and extends 20mm above and 40mm radially away
from the aperture. The symmetry of the chamber allows the problem to be de-
composed into radial and angular components, providing a three-dimensional
simulation at reduced computational cost. The leftmost boundary of the nu-
merical domain is the axis of rotational symmetry. The top and right boundaries
are treated as far-ﬁeld approximations, given the assumption that at an inﬁnite
distance away from the boundary the EGF concentration is zero. These
boundary conditions impose limitations of physically correct behavior on the
system. The bottommost boundary is treated as an inlet that introduces 1 mM
of EGF solution into the computational domain at a proscribed pressure. All
remaining boundaries are treated as solid surfaces (walls), which force the
ﬂuid to a velocity of zero at the boundary. The numerical domain is ﬁlled with
a triangular mesh, which resolves features on the domain as small as 20 nm.
This design of numerical domain ensures physicality of the solution.
Cell culture
MTLn3 breast carcinoma cells were cultured in Dulbecco modiﬁed Eagle
medium (DMEM) supplemented with 5% fetal bovine serum and 100 U/mL
penicillin and 0.1 mg/mL streptomycin (Invitrogen, Carlsbad, CA). The
chamber was set up by adhering the PDMS structure, which deﬁnes the
chamber walls, onto the wafers (containing the channels and apertures),
while using gentle pressure. The MTLn3 breast cancer cells were then
trypsinized and seeded at 103 cells in 100 mL within the space created by the
PDMS. The construct containing the cells was then moved into the metal
housing; the PMMAblockwas placed on top, followed by the lid of the metal
FIGURE 1 Construction of the active
surface. (A) Top view showing the
microchannels and apertures of the mi-
croﬂuidic chip. (B) Cross-sectional lat-
eral view illustrating the UV15 layer on
a cover glass. A microchannel imprinted
on the ﬁlm by photolithography is also
shown. The microchannel measures
203 20 mm in dimension but is reduced
to 1 mm in size at one end. (C) Cross-
sectional frontal view at the 1-mm end of
the microchannel. (D) Spin-coating of a
AZ1818 layer over the microchannel.
(E) Opening of the AZ1818 by lithog-
raphy to produce a 1-mm aperture exit-
ing a microchannel.
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housing. The structure was secured by tightening screws that compressed the
layers within the housing. The cells were incubated at 37C in a 5% CO2-
regulated incubator for 24 h.
Microﬂuidics and time-lapse microscopy
The chamber was set up by adhering the PDMS with holes that deﬁne the
chamber walls onto the active device (containing the channels and apertures)
with gentle pressure and by assembling other layers as described above. The
chamber was then placed on the heated stage (37C) of a laser confocal mi-
croscope (Leica TSP II; Leica, Ernst-Leitz-Strasse, Germany). Flowwas tested
using bromophenol blueas amarker andphase contrastmicroscopy. Imaging of
the gradient and cell chemotaxis were performed using ﬂuorescein isothiocy-
anate (FITC)-conjugated dextran (0.25 mM) alone or together with EGF at
1 mM. The conjugates and factors were placed in the tubing connected to the
chamber using a syringe. The tubing was then connected to a compressed air
outlet, and the air pressure was increased at the onset of the experiment to 0.7
bar. Time-lapsed sequences were generated by confocal or phase contrast mi-
croscopy using a 203 objective at 30-s intervals to record the formation of the
gradient and cell activity.
Image analysis
The line drawing feature and intensity measurement functions were used in
the public domain, Java-based image processing program developed at the
National Institutes of Health (Image J) to obtain intensity values with dis-
tance from the opening of the aperture and across the horizontal surface of the
chamber. Three separate line intensity measurements were obtained for each
frame of the series. The data were transferred to Excel (Microsoft, Redmond,
WA); the intensity readings were averaged and plotted as an intensity curve
over distance. Directionality measured in terms of cos u-values and instan-
taneous speed have been previously described in detail (10). In brief, the
directional change of the cell is deﬁned as the shift in its centroid position
relative to the direction of the gradient. The outline for each cell was traced,
and the change in direction of the cells in degrees (u) was measured for each
frame based on their centroid positions. Cos u-values were obtained where
values close to 1 indicated close reference to the direction of the gradient and
values that deviated closer to zero indicated random directions. Instantaneous
speed was calculated as the distance between the centroid positions of frame
n-1 and frame n divided by the time-lapse interval (30 s) and was the average
value obtained for the duration of the assay (5 min).
RESULTS AND DISCUSSION
Physical mechanism
The processes of creating small, high aspect ratio features in
thick substrates normally require anisotropic plasma etching,
which is expensive and incurs etch bias anomalies (14,15).
The method described here, using a thin substrate, works well
in the lithographic generation of micrometer-size apertures
over microﬂuidic channels. The requirements for the cham-
ber were to accommodate several microchannels on a trans-
parent, 200-mm thick substrate, and the channels were to be
opened by a 1mm3 1mmaperture on one end and to connect
to a reservoir/inlet at the other end. It was further a require-
ment that, through pressure, a feeding ﬂuid could be pumped
FIGURE 2 Construction of the planar microﬂuidic device. (A) Cross-sectional frontal view illustrating the active AZ1818 surface with a single 1-mm
aperture overlying a microchannel imprinted on UV15. The PDMS layer contains two openings of 6 mm in diameter and seals onto the AZ1518 layer. The
PDMS openings deﬁne the walls of the chamber as shown and the reservoir/inlet (not shown). The PMMA block has an opening at the chamber that
superimposes the PDMS opening. The PMMA is rigid and helps compress and seal the layers when encased by the metal housing. The housing contains screws
that can be tightened to improve the seal. (B) A lateral view in cross section demonstrating that the microchannel opens to an aperture on the AZ1518 surface
inside the cell chamber and connects this outlet to the reservoir/inlet on its other end. The PMMA block, which has a plastic tube insert with a 1-mm inner
diameter, is placed over the PDMS. The tubing is directed into the reservoir. (C) The sealed chamber on a microscope stage. Once sealed, a syringe is used to ﬁll
the reservoir with tracer/chemoattractant. The tubing is then connected on the other end to a compressed air outlet. Pressure applied at 0.7 bar at the start of the
experiment is sufﬁcient to conduct the tracer/chemoattractant from the reservoir into the microchannels and through the apertures into the buffer-ﬁlled chamber.
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from the reservoir through the channels to the open tank
framed by PDMS walls. The purpose of the aperture is to
restrict the ﬂow to create a sharply deﬁned diffusion gradient
of the feeding ﬂuid into the water-based tank (Figs. 1 and 2).
The adhesion of the AZ1518 layer containing the apertures
was excellent throughout the experiment.
Modeled gradients
The model of the micropipette is a two-dimensional cross
section through the center pipette. The smallest feature of the
numerical domain is resolved; that is, the space between the
tip of the pipette and the substrate has at least 20 grid points
occupying it. In other words, the 1-mm aperture of the pipette
is divided into 1/10 mm grid spacing around the opening of
the pipette aperture. The boundaries that lead into free space
have outﬂow boundary conditions, and the walls of the de-
vice have no-slip, zero velocity boundary conditions. The
aperture of the micropipette is modeled using an inﬂow
boundary condition.
The numerical method solves the standard laminar ﬂow
Navier-Stokes equations,
FIGURE 3 Modeling the microﬂuidic
gradient from (A) the PD and (B) the
MA. Both devices operate on the prin-
ciple of the generation of steep gradients
for cellular processes. (A) The PD de-
vice produces an active horizontal gra-
dient that results from a vertical ﬂow of
chemoattractant. Due to rotational sym-
metry, only an axisymmetric slice was
modeled. (B) The MA device generates
a horizontal gradient from ﬂow deliv-
ered at an angle and at a position 7 mm
below the active surface. The aperture of
the micropipette abuts the side wall of a
coverslip on top of which cells are
grown. The resulting gradient formed
on the active plane is steep. The PD
gradient was compared with that pro-
duced from MA; the latter was previ-
ously shown to stimulate cancer cell
chemotaxis. The simulations were per-
formed using the computational ﬂuid
dynamics-ACE package (ESI US R&D.,
Huntsville, AL) to solve the Navier-
Stokes and mass diffusion equations on
an unstructured tetrahedral gird. A radial
coordinate system and a two-dimensional
section was used for the PD and MA
devices, respectively, as appropriate for
their symmetries. The gird places were at
least 10 points across the smallest feature
of the device (generally 100-nm grid
spacing). The solver was iterated until
the solution residual differed by less than
1 part in 1000. The results indicate that
the simulated gradients for both devices
are very similar whereby 1 mM of EGF
present in either the PD microchannels or
MA micropipette becomes rapidly re-
duced to physiological levels of 10–50
nM from within 40 mm away from the
source.
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r
Dv
Dt
¼ =  sij1 f;
where
where the diagonal matrix r is the pressure matrix and s is
the viscous stress tensor, which describes the response of the
ﬂuid. The ﬂuid (water) is assumed incompressible and
Newtonian, which implies the following:
t ¼ m @u
@y;
where m is the viscosity of the ﬂuid. The diffusions of species
is modeled using the diffusivity equation where the species
has a diffusion coefﬁcient of D.
The numerical scheme is a discretization of the above
equations, solved using ﬁnite volumemethods with a second-
order upwind scheme. The discretization of the geometric
domain is tessellated with a triangular mesh, resolving fea-
tures as cited above.
The 1-mm diameter pipette numerical domain is shown in
(Fig. 3 B). No symmetry exists as in the case of the modiﬁed
MA, and so a two-dimensional ‘‘cut’’ is taken through the
middle of the pipette. For the PD, similar conditions are ap-
plied to this geometry as to MA: the outlet boundaries are far-
ﬁeld in nature, the end of the pipette is the inlet for EGF, and
all other surfaces are solid walls.
Computer simulations demonstrated that the gradient from
the PD system (Fig. 3 A) was similar to one generated using a
MA (Fig. 3 B). The aperture size of the current planar system
is 1 mm—the same as the dimension of the bore of the mi-
cropipette. The latter was abutted against the wall of a cov-
erslip, 7 mm below the level of the coverslip surface where
cells were grown. The MA method was previously shown to
create a very steep gradient at the cell surface that was suit-
able for cancer cell chemotaxis (10). In the current PD set-up,
the gradient that was formed at the opening of the aperture
was similar in shape and steepness compared to the MA as-
say. The premise behind both chambers lies in the steep
gradient that is created within a 40-mm perimeter around the
apertures along the horizontal surface.
Empirical gradients
The ﬂow through the microchannels was tested using India ink
and bromophenol blue (S. Fok, P. Domachuk, G. Rosengarten,
N. Krause, F. Braet, B. Eggleton, and L. Soon, unpublished
observations). To establish the kinetics and steady-state
conditions of the gradient, a ﬂuorescent marker, ﬂuorescein-
conjugated dextran, was used and a time-lapse sequence was
performed to record the intensity of ﬂuorescence over time
(Fig. 4). Reconstruction of the movies demonstrated that the
gradient was established by around 50 s after pressure ap-
plication of 0.7 bar (Fig. 4 B). Analysis of the change in in-
tensity over distance from the aperture showed that the
gradient established was steep and similar to one generated
using the MA assay (Fig. 4 C), which also recapitulated data
obtained from computer simulations (Fig. 3).
Analysis of cell protrusion
Chemotaxis consists of several steps performed by cells in a
dynamic, integrated sequence. These steps include the initial
detection of chemoattractant through cell surface receptors,
the internal polarization of biochemical factors that set the
direction of movement, cell protrusion, adhesion, deadhesion,
and cell translocation (3). We show that it is possible to
monitor the behavior of cancer cells in the ﬁrst 5 min after
EGF stimulation, which provides information about the early
chemotaxis steps including protrusion. MTLn3 breast carci-
noma cells were seeded overnight onto collagen 1-coated
chambers, which were then placed onto the microscope stage
for time-lapse microscopy (Fig. 5 A). The cells were exposed
either to a gradient of EGF or buffer alone, and time-lapsed
images were acquired at 30-s intervals. The ﬁrst 5 min of cell
activation were analyzed for directionality and instantaneous
speed. Cell directionality was measured as the deviation of
the cell’s centroid direction relative to the direction of the
EGF gradient during the course of the assay (Material and
Methods). In the ﬁrst 5 min after activation, the cancer cells
demonstrated directionality preference toward the EGF gra-
dient, as shown by before and after cell contour maps (Fig.
5 B) and cos u measurements (Fig. 5 C). As cells move to-
ward the gradient, the value of cos u will lie close to 1; if the
cells move in the opposite direction to that of the gradient,
however, cos u-values veer toward1. The results show that,
in the ﬁrst 5 min after EGF activation, the cells responded by
polarizing toward the gradient (Fig. 5 B) and by demon-
strating a mean cos u-value of 0.68 6 0.12. This is signiﬁ-
cantly different from control cells, which showed an average
cos u of 0 6 0.26 (Fig. 5 C).
Instantaneous speed, calculated as the rate of cell move-
ment between successive cell frames, essentially measured
protrusion rates, because the most profound change that oc-
curred in the ﬁrst 5 min was the spread of the lammellipod at
the cell front. The instantaneous speeds measured in the ex-
sij ¼
sxx txy txz
tyx syy tyz
tzx tzy szz
0
@
1
A ¼ 
p 0 0
0 p 0
0 0 p
0
@
1
A1
sxx1 p txy txz
tyx syy1 p tyz
tzx tzy szz1 p
0
@
1
A;
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periments indicate that cells formed protrusions at a faster
rate in the presence of EGF compared to control buffer
conditions. The mean of the instantaneous speed, 0.56 0.05
mm/min, is similar to that of published data for cancer cell
chemotaxis, 0.57 6 0.04 mm/min, toward EGF (10).
These results demonstrate that the planar chamber can be
used to evaluate the ﬁrst few steps of chemotaxis that include
directional protrusion. It will also be possible to study other
early events such as receptor activation and sensing, given
the rapid stabilization of the gradient. The ability to perform
these studies on amoeboid-like cancer cells such as MTLn3
was previously restricted to single-cell micropipette stimu-
lation at a short distance (10 mm) from the cell over a similar
5-min period (2). The current capability of the PD to image
and analyze multiple cells is an advantage over older sys-
tems. This functionality is appropriate for investigations on
cytoskeletal restructuring and receptor redistribution, such as
early events in the process of chemotaxis (16). The use of the
current PD chamber can be easily extended to longer che-
motaxis assays for the study of individual components/steps
of the process and the dynamic chemotaxis cycle itself.
Advantages and some limitations
There are several practical advantages to using the current PD
rather than theMA (10). TheMA device is not stably bonded;
several loose parts are assembled before the experiment. The
process involves growing cells separately on glass coverslips,
transferring these coverslips onto a glass bottom chamber,
and positioning of the micropipette to a distance of 17 mm
below the coverslip. In the PD, the assembly process is un-
necessary as all the parts are ‘‘built-in’’. The cells, for ex-
ample, are grown in the chamber provided. Similar to the MA
device, the chemoattractant is delivered from below the
FIGURE 4 Empirical analysis of gradients. (A) The reservoir was loaded with ﬁltered FITC-dextran through the tubing, the device was enclosed in the metal
encasing, and the whole structure placed on an inverted microscope. The other end of the tubing was connected to a compressed air outlet and pressure was
applied at 0.7 bars. The ﬂuorescent dye was observed to travel from the reservoir, across the microchannels, and was released at the apertures. The confocal
image shows the release of FITC-labeled dextran and the presence of a gradient around the aperture. (B) The speed of gradient formation was analyzed over
time from 0 s at the start of pressure induction. Steady-state extrusion was observed by 50 s when the gradient had stabilized at various distances from the
aperture, as illustrated by the plateau in the graph. (C) The steady-state gradient was compared empirically for both the PD and MD devices. Line intensity
measurements were made with distance from the source of the dye over 1 h. The average intensities were plotted against distance, and the graphs show a steep
slope for the two gradients indicating that the gradients fall sharply with distance from the source.
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surface of cell growth, occurring through apertures that are,
in turn, linked to underlying microchannels. Therefore, there
is no need for assembly of the delivery parts, which is unlike
the MA device. Furthermore, whereas the MA device is re-
stricted to one micropipette delivery source, the PD device
can be conﬁgured to have many apertures of different sizes.
Multiple apertures are advantageous because this permits
simultaneous imaging of multiple events for more efﬁcient
collection of statistical information over the entire experi-
ment.
It was discovered that an overnight incubation in solution
at 37C, as required for cell culture, had caused the UV15
layer containing the microchannels to become susceptible to
slow separation from the glass substrate. This was observed
as small bubbles in the layers. Although this susceptibility
did not hinder our experiments, future chambers should be
constructed with a different substrate, such as SU8, to over-
come the separation problem. Another limitation of the cur-
rent conﬁguration is the restriction to the use of low NA, 203
objective lenses due to the additional height imposed by the
metal casing. Therefore, despite the optimal combined
thicknesses of the microchannel and the aperture layers of
;0.17 mm, the use of higher NA lenses is prohibited due to
their shorter working distances. However, future devices
could be plasma-bonded; such devices would not require the
metal encasing and so enable high-resolution light optical
imaging. The transparent glass layers permit the use of the
device for a variety of optical techniques including ﬂuores-
cence, phase contrast, and digital interference contrast mi-
croscopy.
Although it has not been studied in tumor microenviron-
ments, a steep gradient of factors have been described in vivo
and modeled by computer simulations in heart physiology.
The premise of the work by Yoshioka et al (17), lies in the
EGF secretion by a cardiomyocyte that led to the down-
regulation of the gap junction protein, connexin 43, causing
the disruption of cell-to-cell communication. Reduced con-
nexin expression is associated with various chronic heart
diseases including hypertrophy. The in vivo experiment
consisted of nonuniform EGF gene transfer into car-
diomyocytes, demonstrating that containment of EGF ex-
pression caused hypertrophy in neighboring but not distant
cells. These data supported modeling exercises using a model
of a cardiomyocyte surrounded by capillaries and extracel-
lular matrix, where it was shown that the capillaries acted as a
sink that removed diffused EGF. This action resulted in a
sharp gradient of EGF in the cell’s vicinity that stimulated
only adjacent but not distant cells.
The tumor microenvironment is varied and dynamic but
also highly vascularized. Therefore, it is possible that steep
gradients are also present in tumors similar to conditions in
the heart. These gradients might play an important role in
stimulating the chemotaxis and invasion of cancer cells. By
inference, high levels of protrusive and migratory behavior of
cancer cells have been observed when they are in close
proximity to blood vessels and macrophages. Similar to
cardiomyocytes that are cultured in vitro (17), sharp gradients
are not observed in the in vitro culture of cancer cells due to
the lack of a microvasculature architectural system found in
vivo. However, with the use of microﬂuidic technology as
FIGURE 5 Analysis of cell protrusion. MTLn3 breast
carcinoma cells were seeded in a chamber coated with 10
mg/mL of collagen I. Time-lapsed microscopy was per-
formed acquiring an image at every 30-s interval. The
image stack was analyzed using Image J software to
investigate the parameters of cell protrusion. (A) Phase
contrast image shows cancer cell growth after an overnight
incubation at 37C in a 5% CO2 incubator. (B) Cancer cells
demonstrate changes in cell shape after a 5-min exposure to
the EGF gradient. This is illustrated by the outline of the
cells before (black contour) and after EGF activation (gray
contour). Asterisk indicates position of the aperture and
source of EGF in the chamber. (C) The experiments were
conducted in the absence (con) and presence of an EGF
gradient (EGF) and were analyzed for changes in direc-
tionality. This was performed by calculating the cosine of
the angle of cell deviance from the direction of the gradient
(u) (Materials and Methods). In the presence of an EGF
gradient, cos u is closer to 1, whereas in the absence of a
gradient, cos u nears zero. This indicates that the cells are
more polarized toward the aperture in the presence of an
EGF gradient. The asterisk indicates signiﬁcant difference
in a t-test analysis (p , 0.01); data measure the means of
cos u-values from n ¼ 9 cells. (D) Instantaneous speed,
which measures the speed of movement between succeed-
ing cell frames, was calculated for control and EGF-treated cells. The data show an increase in instantaneous speed in cells activated in the presence of an EGF
gradient compared to control cells. The asterisk indicates signiﬁcant difference in a t-test analysis (p, 0.05); data measure mean of cell speed from n¼ 9 cells.
The experiments were performed twice with similar results.
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demonstrated in this article, it is possible to create such
gradients in vitro that are suitable for the study of cancer cell
chemotaxis (18) and other directional processes such as in-
vasion, axon guidance (19), angiogenesis (20), and branching
morphogenesis (21) to uncover the molecular regulatory
pathways involved.
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